Byotrol released interim results for the six months to 30 September. Despite LBITDA of £0.51m (£0.32m), we expect full-year adjusted EBITDA of £0.1m as a result of contractual payments in excess of £1m in H2. Equally significant is that (i) the company has confirmed that it will file its consumer product formulation with the EPA in the US prior to Christmas; (ii) it is in discussions with a number of global FMCGs over Actizone technology (joint Solvay agreement); and (
13 Dec 2016
Interim results hide true FY picture
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Interim results hide true FY picture
Byotrol plc (BYOT:LON) | 0.1 0 0.0% | Mkt Cap: 0.57m
- Published:
13 Dec 2016 -
Author:
Mark Brewer | Cavendish Research -
Pages:
12
Byotrol released interim results for the six months to 30 September. Despite LBITDA of £0.51m (£0.32m), we expect full-year adjusted EBITDA of £0.1m as a result of contractual payments in excess of £1m in H2. Equally significant is that (i) the company has confirmed that it will file its consumer product formulation with the EPA in the US prior to Christmas; (ii) it is in discussions with a number of global FMCGs over Actizone technology (joint Solvay agreement); and (